Macrophage activation syndrome induced by prolonged treatment with liposomal amphotericin B

Med Clin (Barc). 2018 Jul 23;151(2):84-85. doi: 10.1016/j.medcli.2017.11.020. Epub 2017 Dec 11.

[Article in English, Spanish]

Authors

Gerhard Jung¹, Enric Reverter², Javier Fernández²

Affiliations

¹ Unidad de Cuidados Intensivos Hepática, Hospital Clinic de Barcelona, Instituto de Enfermedades Digestivas y Metabólicas (IMDM), Barcelona, España. Electronic address: gerhard.jung@gmail.com.
² Unidad de Cuidados Intensivos Hepática, Hospital Clinic de Barcelona, Instituto de Enfermedades Digestivas y Metabólicas (IMDM), Barcelona, España.

PMID: 29241868
DOI: 10.1016/j.medcli.2017.11.020

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Amphotericin B / administration & dosage
Amphotericin B / adverse effects*
Antifungal Agents / administration & dosage
Antifungal Agents / adverse effects*
Drug Therapy, Combination
Humans
Macrophage Activation Syndrome / chemically induced*
Macrophage Activation Syndrome / diagnosis
Male
Middle Aged

Substances

Antifungal Agents
liposomal amphotericin B
Amphotericin B